Literature DB >> 19153662

Regulation of mitochondrial aconitase by phosphorylation in diabetic rat heart.

G Lin1, R W Brownsey, K M MacLeod.   

Abstract

Mitochondrial dysfunction and protein kinase C (PKC) activation are consistently found in diabetic cardiomyopathy but their relationship remains unclear. This study identified mitochondrial aconitase as a downstream target of PKC activation using immunoblotting and mass spectrometry, and then characterized phosphorylation-induced changes in its activity in hearts from type 1 diabetic rats. PKCbeta(2) co-immunoprecipitated with phosphorylated aconitase from mitochondria isolated from diabetic hearts. Augmented phosphorylation of mitochondrial aconitase in diabetic hearts was found to be associated with an increase in its reverse activity (isocitrate to aconitate), while the rate of the forward activity was unchanged. Similar results were obtained on phosphorylation of mitochondrial aconitase by PKCbeta(2) in vitro. These results demonstrate the regulation of mitochondrial aconitase activity by PKC-dependent phosphorylation. This may influence the activity of the tricarboxylic acid cycle, and contribute to impaired mitochondrial function and energy metabolism in diabetic hearts.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19153662     DOI: 10.1007/s00018-009-8696-3

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  19 in total

Review 1.  Reactive Oxygen Species in Metabolic and Inflammatory Signaling.

Authors:  Steven J Forrester; Daniel S Kikuchi; Marina S Hernandes; Qian Xu; Kathy K Griendling
Journal:  Circ Res       Date:  2018-03-16       Impact factor: 17.367

2.  Identification of εPKC targets during cardiac ischemic injury.

Authors:  Grant Budas; Helio Miranda Costa; Julio Cesar Batista Ferreira; André Teixeira da Silva Ferreira; Jonas Perales; José Eduardo Krieger; Daria Mochly-Rosen; Deborah Schechtman
Journal:  Circ J       Date:  2012-03-27       Impact factor: 2.993

3.  Iron control of erythroid development by a novel aconitase-associated regulatory pathway.

Authors:  Grant C Bullock; Lorrie L Delehanty; Anne-Laure Talbot; Sara L Gonias; Wing-Hang Tong; Tracey A Rouault; Brian Dewar; Jeffrey M Macdonald; Jason J Chruma; Adam N Goldfarb
Journal:  Blood       Date:  2010-04-20       Impact factor: 22.113

4.  Phosphoprotein abundance changes in hypertensive cardiac remodeling.

Authors:  Kumar Kotlo; Keven R Johnson; Jean M Grillon; David L Geenen; Pieter deTombe; Robert S Danziger
Journal:  J Proteomics       Date:  2012-05-31       Impact factor: 4.044

5.  Inhibition of aldehyde dehydrogenase 2 by oxidative stress is associated with cardiac dysfunction in diabetic rats.

Authors:  Jiali Wang; Haigang Wang; Panpan Hao; Li Xue; Shujian Wei; Yun Zhang; Yuguo Chen
Journal:  Mol Med       Date:  2010-10-15       Impact factor: 6.354

6.  Rediscovering medicinal plants' potential with OMICS: microsatellite survey in expressed sequence tags of eleven traditional plants with potent antidiabetic properties.

Authors:  Jagajjit Sahu; Priyabrata Sen; Manabendra Dutta Choudhury; Budheswar Dehury; Madhumita Barooah; Mahendra Kumar Modi; Anupam Das Talukdar
Journal:  OMICS       Date:  2014-05

7.  Fatty acid chain elongation in palmitate-perfused working rat heart: mitochondrial acetyl-CoA is the source of two-carbon units for chain elongation.

Authors:  Janos Kerner; Paul E Minkler; Edward J Lesnefsky; Charles L Hoppel
Journal:  J Biol Chem       Date:  2014-02-20       Impact factor: 5.157

Review 8.  Aconitase post-translational modification as a key in linkage between Krebs cycle, iron homeostasis, redox signaling, and metabolism of reactive oxygen species.

Authors:  Oleh V Lushchak; Marta Piroddi; Francesco Galli; Volodymyr I Lushchak
Journal:  Redox Rep       Date:  2013-11-22       Impact factor: 4.412

Review 9.  Conundrum of pathogenesis of diabetic cardiomyopathy: role of vascular endothelial dysfunction, reactive oxygen species, and mitochondria.

Authors:  Mandip Joshi; Sainath R Kotha; Smitha Malireddy; Vaithinathan Selvaraju; Abhay R Satoskar; Alexender Palesty; David W McFadden; Narasimham L Parinandi; Nilanjana Maulik
Journal:  Mol Cell Biochem       Date:  2013-12-04       Impact factor: 3.396

10.  Angiotensin receptor blockade recovers hepatic UCP2 expression and aconitase and SDH activities and ameliorates hepatic oxidative damage in insulin resistant rats.

Authors:  Priscilla Montez; José Pablo Vázquez-Medina; Rubén Rodríguez; Max A Thorwald; José A Viscarra; Lisa Lam; Janos Peti-Peterdi; Daisuke Nakano; Akira Nishiyama; Rudy M Ortiz
Journal:  Endocrinology       Date:  2012-10-18       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.